Literature DB >> 27505672

Mitochondrial Akt Regulation of Hypoxic Tumor Reprogramming.

Young Chan Chae1, Valentina Vaira2, M Cecilia Caino1, Hsin-Yao Tang3, Jae Ho Seo1, Andrew V Kossenkov4, Luisa Ottobrini5, Cristina Martelli3, Giovanni Lucignani6, Irene Bertolini7, Marco Locatelli8, Kelly G Bryant1, Jagadish C Ghosh1, Sofia Lisanti1, Bonsu Ku9, Silvano Bosari7, Lucia R Languino10, David W Speicher11, Dario C Altieri12.   

Abstract

Hypoxia is a universal driver of aggressive tumor behavior, but the underlying mechanisms are not completely understood. Using a phosphoproteomics screen, we now show that active Akt accumulates in the mitochondria during hypoxia and phosphorylates pyruvate dehydrogenase kinase 1 (PDK1) on Thr346 to inactivate the pyruvate dehydrogenase complex. In turn, this pathway switches tumor metabolism toward glycolysis, antagonizes apoptosis and autophagy, dampens oxidative stress, and maintains tumor cell proliferation in the face of severe hypoxia. Mitochondrial Akt-PDK1 signaling correlates with unfavorable prognostic markers and shorter survival in glioma patients and may provide an "actionable" therapeutic target in cancer.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Akt; PDK1; hypoxia; metabolism; mitochondria; tumor cell proliferation

Mesh:

Substances:

Year:  2016        PMID: 27505672      PMCID: PMC5131882          DOI: 10.1016/j.ccell.2016.07.004

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  44 in total

1.  Role of PFKFB3-driven glycolysis in vessel sprouting.

Authors:  Katrien De Bock; Maria Georgiadou; Sandra Schoors; Anna Kuchnio; Brian W Wong; Anna Rita Cantelmo; Annelies Quaegebeur; Bart Ghesquière; Sandra Cauwenberghs; Guy Eelen; Li-Kun Phng; Inge Betz; Bieke Tembuyser; Katleen Brepoels; Jonathan Welti; Ilse Geudens; Inmaculada Segura; Bert Cruys; Franscesco Bifari; Ilaria Decimo; Raquel Blanco; Sabine Wyns; Jeroen Vangindertael; Susana Rocha; Russel T Collins; Sebastian Munck; Dirk Daelemans; Hiromi Imamura; Roland Devlieger; Mark Rider; Paul P Van Veldhoven; Frans Schuit; Ramon Bartrons; Johan Hofkens; Peter Fraisl; Sucheta Telang; Ralph J Deberardinis; Luc Schoonjans; Stefan Vinckier; Jason Chesney; Holger Gerhardt; Mieke Dewerchin; Peter Carmeliet
Journal:  Cell       Date:  2013-08-01       Impact factor: 41.582

2.  Validation of an engineered cell model for in vitro and in vivo HIF-1α evaluation by different imaging modalities.

Authors:  A Lo Dico; S Valtorta; C Martelli; S Belloli; U Gianelli; D Tosi; S Bosari; A Degrassi; M Russo; I Raccagni; G Lucignani; R M Moresco; L Ottobrini
Journal:  Mol Imaging Biol       Date:  2014-04       Impact factor: 3.488

Review 3.  PI3K and cancer: lessons, challenges and opportunities.

Authors:  David A Fruman; Christian Rommel
Journal:  Nat Rev Drug Discov       Date:  2014-02       Impact factor: 84.694

Review 4.  Why do cancers have high aerobic glycolysis?

Authors:  Robert A Gatenby; Robert J Gillies
Journal:  Nat Rev Cancer       Date:  2004-11       Impact factor: 60.716

5.  HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia.

Authors:  Jung-whan Kim; Irina Tchernyshyov; Gregg L Semenza; Chi V Dang
Journal:  Cell Metab       Date:  2006-03       Impact factor: 27.287

Review 6.  Hypoxia and the extracellular matrix: drivers of tumour metastasis.

Authors:  Daniele M Gilkes; Gregg L Semenza; Denis Wirtz
Journal:  Nat Rev Cancer       Date:  2014-05-15       Impact factor: 60.716

7.  The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase.

Authors:  Alison Gartland; Janine T Erler; Thomas R Cox; Robin M H Rumney; Erwin M Schoof; Lara Perryman; Anette M Høye; Ankita Agrawal; Demelza Bird; Norain Ab Latif; Hamish Forrest; Holly R Evans; Iain D Huggins; Georgina Lang; Rune Linding
Journal:  Nature       Date:  2015-05-27       Impact factor: 49.962

8.  The vacuolar H+ ATPase is a novel therapeutic target for glioblastoma.

Authors:  Andrea Di Cristofori; Stefano Ferrero; Irene Bertolini; Gabriella Gaudioso; Maria Veronica Russo; Valeria Berno; Marco Vanini; Marco Locatelli; Mario Zavanone; Paolo Rampini; Thomas Vaccari; Manuela Caroli; Valentina Vaira
Journal:  Oncotarget       Date:  2015-07-10

9.  Autophagy mediates HIF2α degradation and suppresses renal tumorigenesis.

Authors:  X-D Liu; J Yao; D N Tripathi; Z Ding; Y Xu; M Sun; J Zhang; S Bai; P German; A Hoang; L Zhou; D Jonasch; X Zhang; C J Conti; E Efstathiou; N M Tannir; N T Eissa; G B Mills; C L Walker; E Jonasch
Journal:  Oncogene       Date:  2014-07-07       Impact factor: 9.867

10.  Bead-based profiling of tyrosine kinase phosphorylation identifies SRC as a potential target for glioblastoma therapy.

Authors:  Jinyan Du; Paula Bernasconi; Karl R Clauser; D R Mani; Stephen P Finn; Rameen Beroukhim; Melissa Burns; Bina Julian; Xiao P Peng; Haley Hieronymus; Rebecca L Maglathlin; Timothy A Lewis; Linda M Liau; Phioanh Nghiemphu; Ingo K Mellinghoff; David N Louis; Massimo Loda; Steven A Carr; Andrew L Kung; Todd R Golub
Journal:  Nat Biotechnol       Date:  2008-12-21       Impact factor: 54.908

View more
  63 in total

1.  Akt-mediated phosphorylation of MICU1 regulates mitochondrial Ca2+ levels and tumor growth.

Authors:  Saverio Marchi; Mariangela Corricelli; Alessio Branchini; Veronica Angela Maria Vitto; Sonia Missiroli; Giampaolo Morciano; Mariasole Perrone; Mattia Ferrarese; Carlotta Giorgi; Mirko Pinotti; Lorenzo Galluzzi; Guido Kroemer; Paolo Pinton
Journal:  EMBO J       Date:  2018-11-30       Impact factor: 11.598

Review 2.  Hypoxia and cellular metabolism in tumour pathophysiology.

Authors:  Scott K Parks; Yann Cormerais; Jacques Pouysségur
Journal:  J Physiol       Date:  2017-02-19       Impact factor: 5.182

3.  Tumour metabolism: Adapting to harsh conditions.

Authors:  Sarah Seton-Rogers
Journal:  Nat Rev Cancer       Date:  2016-08-26       Impact factor: 60.716

4.  Insulin-like growth factor 1 signaling is essential for mitochondrial biogenesis and mitophagy in cancer cells.

Authors:  Amy Lyons; Michael Coleman; Sarah Riis; Cedric Favre; Ciara H O'Flanagan; Alexander V Zhdanov; Dmitri B Papkovsky; Stephen D Hursting; Rosemary O'Connor
Journal:  J Biol Chem       Date:  2017-08-18       Impact factor: 5.157

5.  Double genetic disruption of lactate dehydrogenases A and B is required to ablate the "Warburg effect" restricting tumor growth to oxidative metabolism.

Authors:  Maša Ždralević; Almut Brand; Lorenza Di Ianni; Katja Dettmer; Jörg Reinders; Katrin Singer; Katrin Peter; Annette Schnell; Christina Bruss; Sonja-Maria Decking; Gudrun Koehl; Blanca Felipe-Abrio; Jérôme Durivault; Pascale Bayer; Marie Evangelista; Thomas O'Brien; Peter J Oefner; Kathrin Renner; Jacques Pouysségur; Marina Kreutz
Journal:  J Biol Chem       Date:  2018-08-29       Impact factor: 5.157

Review 6.  New insights into autophagy in hepatocellular carcinoma: mechanisms and therapeutic strategies.

Authors:  Shuo Yang; Liang Yang; Xinyu Li; Bowen Li; Yan Li; Xiaodong Zhang; Yingbo Ma; Xueqiang Peng; Hongyuan Jin; Hangyu Li
Journal:  Am J Cancer Res       Date:  2019-07-01       Impact factor: 6.166

Review 7.  Promising new treatments for pancreatic cancer in the era of targeted and immune therapies.

Authors:  Ahmed Elaileh; Ashish Saharia; Lucy Potter; Flavio Baio; Afnan Ghafel; Maen Abdelrahim; Kirk Heyne
Journal:  Am J Cancer Res       Date:  2019-09-01       Impact factor: 6.166

8.  Systems biology-based drug repositioning identifies digoxin as a potential therapy for groups 3 and 4 medulloblastoma.

Authors:  Lei Huang; Sarah Garrett Injac; Kemi Cui; Frank Braun; Qi Lin; Yuchen Du; Huiyuan Zhang; Mari Kogiso; Holly Lindsay; Sibo Zhao; Patricia Baxter; Adesina Adekunle; Tsz-Kwong Man; Hong Zhao; Xiao-Nan Li; Ching C Lau; Stephen T C Wong
Journal:  Sci Transl Med       Date:  2018-10-24       Impact factor: 17.956

9.  Skp2-mediated ubiquitination and mitochondrial localization of Akt drive tumor growth and chemoresistance to cisplatin.

Authors:  Xinfang Yu; Ruike Wang; Yangnan Zhang; Li Zhou; Wei Wang; Haidan Liu; Wei Li
Journal:  Oncogene       Date:  2019-08-21       Impact factor: 9.867

10.  Quantitative ubiquitylome analysis and crosstalk with proteome/acetylome analysis identified novel pathways and targets of perifosine treatment in neuroblastoma.

Authors:  Min Jiang; Zhongyan Hua; Yudi Dong; Zhihui Liu; Carol J Thiele; Zhijie Li
Journal:  Transl Cancer Res       Date:  2018-12       Impact factor: 1.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.